Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man.

[1]  W. Marsh,et al.  The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. , 2015, The American review of respiratory disease.

[2]  K. Chung,et al.  Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man. , 1988, The Journal of allergy and clinical immunology.

[3]  R. Patterson,et al.  The bronchoconstrictor properties of platelet-activating factor in humans. , 1987, The American review of respiratory disease.

[4]  R. Schellenberg.  Airway responses to platelet-activating factor. , 1987, The American review of respiratory disease.

[5]  K. Chung,et al.  PAF closely mimics pathology of asthma , 1987 .

[6]  K. Chung,et al.  Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. , 1987, Journal of applied physiology.

[7]  N. Voelkel,et al.  Metabolism of platelet-activating factor in isolated perfused rat lung. , 1987, The Journal of clinical investigation.

[8]  A. Wardlaw,et al.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.

[9]  F. Cuss,et al.  EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MAN , 1986, The Lancet.

[10]  B. Vargaftig,et al.  ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MAN , 1986, The Lancet.

[11]  K. Chung,et al.  Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. , 1986, The Journal of pharmacology and experimental therapeutics.

[12]  V. Lagente,et al.  Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. , 1985, Biochemical and biophysical research communications.

[13]  K. Chung,et al.  Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs. , 1985, Journal of applied physiology.

[14]  C. Chesney,et al.  Desensitization of human platelets by platelet activating factor. , 1985, Biochemical and biophysical research communications.

[15]  P. O'Byrne,et al.  Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. , 1984, The American review of respiratory disease.

[16]  B. Vargaftig,et al.  The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene , 1984, British journal of pharmacology.

[17]  P. Barnes,et al.  Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.

[18]  J. Vane,et al.  Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation. , 1980, Prostaglandins.

[19]  S. Heptinstall,et al.  RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION , 1988, The Lancet.

[20]  P. Barnes.  Platelet-activating factor and asthma. , 1988, The Journal of allergy and clinical immunology.

[21]  M. Philpott.  Letter: Infant feeds and softened water. , 1975, Lancet.